Filing Flows › Oscar Health (OSCR) › Q2 2026
Oscar Health (OSCR) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
Oscar Health (OSCR) reported revenue of $4.9B for the second quarter 2026 (Q2 2026), +70% from a year earlier and +5% from the quarter before. Operating margin was 8.0%, net earnings $362M (7.4% of revenue).
Oscar Health, Q2 2026: revenue $4.9B (+70% year over year), operating margin 8.0%, net earnings $362M, operating cash flow $2.1B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.9B | +5% | +70% |
| Operating profit | $389M | -45% | — |
| Net earnings | $362M | -47% | — |
| Operating cash flow | $2.1B | -20% | +311% |
| Free cash flow | $2.1B | -20% | +316% |
What changed
Revenue was $4.9B in Q2 2026, up 70% year over year and up 5% from the previous quarter.
Operating profit was $0.39B, a 8.0% margin (up 16.0 points year over year). Total costs grew 45% against revenue growth of 70%. The fastest-growing cost line was Other operating costs (+48%). Net earnings were $0.36B. The effective tax rate was 5.5%.
Operating cash flow was $2.1B (up 311% year over year), 578% of net earnings. Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $1.7B. Capital expenditures of $0.01B left free cash flow of $2.1B.
Questions
What was Oscar Health's revenue in the second quarter 2026?
Oscar Health (OSCR) reported revenue of $4.9B for the second quarter 2026 (Q2 2026), +70% from a year earlier and +5% from the quarter before.
Was Oscar Health profitable in the second quarter 2026?
Operating profit was $389M (8.0% of revenue) and net earnings $362M.
Source: Oscar Health 10-Q on SEC EDGAR.